Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.

Détails

Ressource 1Télécharger: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis.pdf (739.07 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_3456ED032F5F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
Périodique
Journal of hepatology
Auteur⸱e⸱s
Geidl-Flueck B., Hochuli M., Németh Á., Eberl A., Derron N., Köfeler H.C., Tappy L., Berneis K., Spinas G.A., Gerber P.A.
ISSN
1600-0641 (Electronic)
ISSN-L
0168-8278
Statut éditorial
Publié
Date de publication
07/2021
Peer-reviewed
Oui
Volume
75
Numéro
1
Pages
46-54
Langue
anglais
Notes
Publication types: Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
Excessive fructose intake is associated with increased de novo lipogenesis, blood triglycerides, and hepatic insulin resistance. We aimed to determine whether fructose elicits specific effects on lipid metabolism independently of excessive caloric intake.
A total of 94 healthy men were studied in this double-blind, randomized trial. They were assigned to daily consumption of sugar-sweetened beverages (SSBs) containing moderate amounts of fructose, sucrose (fructose-glucose disaccharide) or glucose (80 g/day) in addition to their usual diet or SSB abstinence (control group) for 7 weeks. De novo fatty acid (FA) and triglyceride synthesis, lipolysis and plasma free FA (FFA) oxidation were assessed by tracer methodology.
Daily intake of beverages sweetened with free fructose and fructose combined with glucose (sucrose) led to a 2-fold increase in basal hepatic fractional secretion rates (FSR) compared to control (median FSR %/day: sucrose 20.8 (p = 0.0015); fructose 19.7 (p = 0.013); control 9.1). Conversely, the same amounts of glucose did not change FSR (median of FSR %/day 11.0 (n.s.)). Fructose intake did not change basal secretion of newly synthesized VLDL-triglyceride, nor did it alter rates of peripheral lipolysis, nor total FA and plasma FFA oxidation. Total energy intake was similar across groups.
Regular consumption of both fructose- and sucrose-sweetened beverages in moderate doses - associated with stable caloric intake - increases hepatic FA synthesis even in a basal state; this effect is not observed after glucose consumption. These findings provide evidence of an adaptative response to regular fructose exposure in the liver.
This study investigated the metabolic effects of daily sugar-sweetened beverage consumption for several weeks in healthy lean men. It revealed that beverages sweetened with the sugars fructose and sucrose (glucose and fructose combined), but not glucose, increase the ability of the liver to produce lipids. This change may pave the way for further unfavorable effects on metabolic health.
NCT01733563.
Mots-clé
Adult, Double-Blind Method, Energy Intake, Fatty Acids/biosynthesis, Fructose/administration & dosage, Fructose/adverse effects, Fructose/metabolism, Glucose/administration & dosage, Glucose/metabolism, Healthy Volunteers, Humans, Lipid Metabolism/drug effects, Lipid Metabolism/physiology, Lipogenesis/drug effects, Lipogenesis/physiology, Lipoproteins, VLDL/biosynthesis, Liver/drug effects, Liver/metabolism, Male, Sucrose/administration & dosage, Sucrose/adverse effects, Sucrose/metabolism, Sugar-Sweetened Beverages, Sweetening Agents/pharmacology, Triglycerides/biosynthesis, carbohydrate, lipid metabolism, liver, stable isotopes, sugar
Pubmed
Web of science
Open Access
Oui
Création de la notice
15/03/2021 15:50
Dernière modification de la notice
20/01/2024 8:16
Données d'usage